Protective immune responses elicited in mice by immunization with formulations of poly (lactide-co-glycolide) microparticles

被引:59
作者
McKeever, U [1 ]
Barman, S [1 ]
Hao, T [1 ]
Chambers, P [1 ]
Song, S [1 ]
Lunsford, L [1 ]
Hsu, YY [1 ]
Roy, K [1 ]
Hedley, ML [1 ]
机构
[1] Zycos Inc, Lexington, MA 02421 USA
关键词
microparticle; DNA; vaccine; PLG;
D O I
10.1016/S0264-410X(01)00509-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Parenteral administration of microparticle encapsulated DNA elicits immune responses to the encoded antigens. Experiments were performed to test whether the addition of certain lipophilic agents to such formulations enhanced the activity of a beta-galactosidase (beta-gal) DNA vaccine. Addition of either taurocholic acid (TA) or monomethoxy polyethylene-glycol-distearoylphosphatidylehanolamine (PEG-DSPE) increased the efficiency of DNA encapsulation. Immunization of mice with encapsulated DNA formulations containing either compound significantly increased the number of antibody positive responders over that achieved with non-lipid containing particles. Moreover, responding animals demonstrated trends towards higher antibody titers and increased T cell responses. Tumor protection against the CT26.CL25 tumor cell line was demonstrated with lipid and non-lipid containing formulations. These results are the first demonstration of protection obtained by parenteral administration of PLG encapsulated DNA vaccines. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1524 / 1531
页数:8
相关论文
共 53 条
  • [1] DNA vaccination: Transfection and activation of dendritic cells as key events for immunity
    Akbari, O
    Panjwani, N
    Garcia, S
    Tascon, R
    Lowrie, D
    Stockinger, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (01) : 169 - 177
  • [2] Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial
    Boyer, JD
    Chattergoon, MA
    Ugen, KE
    Shah, A
    Bennett, M
    Cohen, A
    Nyland, S
    Lacy, KE
    Bagarazzi, ML
    Higgins, TJ
    Baine, Y
    Ciccarelli, RB
    Ginsberg, RS
    MacGregor, RR
    Weiner, DB
    [J]. CLINICAL IMMUNOLOGY, 1999, 90 (01) : 100 - 107
  • [3] Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of β-chemokines
    Boyer, JD
    Cohen, AD
    Vogt, S
    Schumann, K
    Nath, B
    Ahn, L
    Lacy, K
    Bagarazzi, ML
    Higgins, TJ
    Baine, Y
    Ciccarelli, RB
    Ginsberg, RS
    MacGregor, RR
    Weiner, DB
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02) : 476 - 483
  • [4] Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
    Calarota, S
    Bratt, G
    Nordlund, S
    Hinkula, J
    Leandersson, AC
    Sandström, E
    Wahren, B
    [J]. LANCET, 1998, 351 (9112) : 1320 - 1325
  • [5] Calarota SA, 1999, J IMMUNOL, V163, P2330
  • [6] Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope
    Casares, S
    Inaba, K
    Brumeanu, TD
    Steinman, RM
    Bona, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09) : 1481 - 1486
  • [7] Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles
    Chen, SC
    Jones, DH
    Fynan, EF
    Farrar, GH
    Clegg, JCS
    Greenberg, HB
    Herrmann, JE
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (07) : 5757 - 5761
  • [8] Modulating the immune response to genetic immunization
    Cohen, AD
    Boyer, JD
    Weiner, DB
    [J]. FASEB JOURNAL, 1998, 12 (15) : 1611 - 1626
  • [9] CONDON C, 1996, NAT MED, V10, P107
  • [10] Gene vaccination with naked plasmid DNA: Mechanism of CTL priming
    Corr, M
    Lee, DJ
    Carson, DA
    Tighe, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) : 1555 - 1560